Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.
Press releases published on April 16, 2025

CAJO impose une pénalité de 120 000 dollars au Great Canadian Casino Resort Toronto pour un système de tricherie impliquant deux croupiers
TORONTO, 16 avr. 2025 (GLOBE NEWSWIRE) -- Le registrateur de la Commission des alcools et des jeux de l’Ontario (CAJO) a imposé une amende de 120 000 $ à Ontario Gaming GTA Limited Partnership (« Great Canadian Casino Resort Toronto »), alléguant que la …

Aduro Clean Technologies gibt Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 bekannt
LONDON, Ontario, April 16, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für umweltfreundliche Technologien, das die Kraft der Chemie nutzt, um minderwertige …

Aduro Clean Technologies présente les résultats financiers du troisième trimestre de l’exercice fiscal 2025
LONDON, Province de l’Ontario, 16 avr. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. Ci-après « Aduro » ou la « Société », (NASDAQ : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières …

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E …

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®
Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 au 24 avril 2025 au Walter E. …

Die Ascom Generalversammlung genehmigt alle Anträge des Verwaltungsrats
Ad hoc Mitteilung gemäss Art. 53 KR Baar, Schweiz, 16. April 2025 Die Aktionärinnen und Aktionäre der Ascom Holding AG haben an der ordentlichen Generalversammlung vom 16. April 2025 in Zug allen Anträgen des Verwaltungsrats mit grosser Mehrheit …

Ascom Annual General Meeting approves all proposals of the Board of Directors
Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, April 16, 2025 At the Annual General Meeting held on April 16, 2025, in Zug, the shareholders of Ascom Holding AG approved by a large majority all proposals presented by the Board of Directors. …

Medical Express Ambulance, Inc. Data Breach Alert Issued by Wolf Haldenstein
PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman …

Class Action Reminder for SOUN Investors: Kessler Topaz Meltzer & Check, LLP Reminds SoundHound AI, Inc. (SOUN) Investors of Securities Fraud Class Action Lawsuit
RADNOR, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open Lending
Faruqi …

Early Warning Press Release
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- The Cromwell Trust (the “Trust”) transferred 17,136,980 Class A Preferred Shares (“Preferred Shares”) in the capital of Inter-Rock Minerals Inc. (the “Issuer”) to David Crombie on April 16, 2025, and David …

Changes in Nokia Corporation's own shares
Nokia Corporation Stock Exchange Release 16 April 2025 at 18:30 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 5 348 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia' …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
Nokia Oyj Pörssitiedote 16.4.2025 klo 18.30 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 5 348 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

Customer Loyalty Solutions (CLS) Market on a Steady Growth Path: Projected to Grow Through 2030 at CAGR 11.8%
Middleton, Massachusetts, April 16, 2025 (GLOBE NEWSWIRE) -- QKS Group, a premier market intelligence and advisory firm, has released its latest in-depth analysis of the global Customer Loyalty Solutions (CLS) Market, projecting a compound annual growth …

NextNav Announces Appointment of H. Wyman Howard and Lorin Selby to its Board of Directors
RESTON, Va., April 16, 2025 (GLOBE NEWSWIRE) -- NextNav Inc. (NASDAQ: NN), a leader in next-generation position, navigation and timing (PNT) and 3D geolocation, today announced that its board of directors has elected Rear Admiral H. Wyman Howard and Rear …

MG Collectibles and Toys Partners with NPC Labs and Spaciom to Authenticate and Monetize Collectibles with Cutting-Edge Technology
STATEN ISLAND, N.Y., April 16, 2025 (GLOBE NEWSWIRE) -- MG Collectibles and Toys (MGCT), an emerging leader in collectibles and pop culture, has announced a strategic partnership with NPC Labs, experts in intellectual property (IP) solutions for creators, …

Hub Cyber Security Appoints Shlomo Bibas as an Independent Member of the Board of Directors
TEL AVIV, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced data fabric technology, is pleased to announce the appointment of Shlomo Bibas as …

SOUN Investors Have the Opportunity to Lead the SoundHound AI Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi …

ELF Investors Have the Opportunity to Lead the e.l.f. Beauty Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi …

BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease
Cambridge, MA USA, April 16, 2025 (GLOBE NEWSWIRE) -- BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, today announced the publication of the 18-month data from its Phase 1 exPDite clinical trial for …